CeramTec Acquisition Completed; Saleh Named New CEO as Steinmetz Steps Down
Hadi Saleh, Ph.D., formerly president of CeramTec’s Medical division, has been named CEO.
CeramTec Group’s recently announced acquisition by a consortium of investors led by funds advised by BC Partners and including the Public Sector Pension Investment Board and Ontario Teachers’ Pension Plan has received antitrust clearance and was completed on March 8, 2018. In addition, Hadi Saleh, Ph.D., formerly president of the company’s Medical division, has been named CEO. The appointment comes after Henri Steinmetz, CeramTec’s CEO since 2016, left the company with the full mutual agreement of the supervisory board.
“As the group’s president Medical, Dr. Hadi Saleh has demonstrated his professional expertise and outstanding leadership qualities,” said Günter von Au, Ph.D., chairman of CeramTec’s supervisory board. “We are confident that under his guidance, the CeramTec Group will continue its growth trajectory. At the same time, we thank Henri Steinmetz for his successful tenure at the company’s helm and wish him all the very best for the future, both professionally and personally.”
“I would like to maintain and build on the successful growth strategy that we have adopted and further strengthen CeramTec’s competitive position as a global leader in the technical ceramics sector,” said Saleh. “Looking forward to the coming years, we want the group to continue growing, both organically and through acquisitions. Our strategic goal is to turn the company from a German technology leader into a global market leader for innovative materials.”
In his previous role, Saleh oversaw the group’s range of medical products and was co-responsible for its industrial business. Before joining CeramTec in July 2015, he held management positions at U.S. medical technology company Biomet, one of the world’s largest suppliers of orthopedic implants, for over 10 years.
For more information, visit www.ceramtec.com.